{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:53:48Z","timestamp":1784260428805,"version":"3.55.0"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2003,4,9]]},"abstract":"Context<\/jats:title>Adolescent obesity is becoming a national public health problem. Weight-loss medications including sibutramine facilitate weight control in adults and could be used with obese adolescents in combination with behavior therapy (BT).<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine whether increased weight loss in obese adolescents is induced when sibutramine is added to a family-based, behavioral weight control program.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>Randomized, double-blind, placebo-controlled trial consisting of 82 adolescents aged 13 to 17 years with a body mass index (BMI) of 32 to 44 conducted from March 1999 to August 2002 at a university-based clinic for 6 months, followed by open-label treatment during months 7 to 12.<\/jats:p><\/jats:sec>Interventions<\/jats:title>For the first 6 months, participants received either BT and sibutramine or BT and placebo. From months 7 to 12, all participants received sibutramine in open-label treatment.<\/jats:p><\/jats:sec>Main Outcome Measures<\/jats:title>Percentage change in BMI; systolic and diastolic blood pressure and pulse; and hunger.<\/jats:p><\/jats:sec>Results<\/jats:title>In intention-to-treat analysis at month 6, participants in the BT and sibutramine group lost a mean (SD) of 7.8 kg (6.3 kg) and had an 8.5% (6.8%) reduction in BMI, which was significantly more than weight loss of 3.2 kg (6.1 kg) and reduction in BMI of 4.0% (5.4%) in the BT and placebo group. Significantly greater reductions in hunger (P<\/jats:italic> = .002) also were reported by participants who received BT and sibutramine. From months 7 to 12, adolescents initially treated with sibutramine gained 0.8 kg (10.5 kg) with continued use of the medication, whereas those who switched from placebo to sibutramine lost an additional 1.3 kg (5.4 kg). Medication dose was reduced (n = 23) or discontinued (n = 10) to manage increases in blood pressure, pulse rate, or other symptoms.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>The addition of sibutramine to a comprehensive behavioral program induced significantly more weight loss than did BT and placebo. Until more extensive safety and efficacy data are available, medications for weight loss should be used only on an experimental basis in adolescents and children.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jama.289.14.1805","type":"journal-article","created":{"date-parts":[[2003,4,10]],"date-time":"2003-04-10T01:20:03Z","timestamp":1049937603000},"page":"1805","source":"Crossref","is-referenced-by-count":289,"title":["Behavior Therapy and Sibutramine for the Treatment of Adolescent Obesity"],"prefix":"10.1001","volume":"289","author":[{"given":"Robert I.","family":"Berkowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Wadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Tershakovec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna L.","family":"Cronquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"ref-joc30109-1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1001\/archpedi.1995.02170230039005","article-title":"Overweight prevalence and trends for children and adolescents: the national health and examination survey, 1963 to 1991.","volume":"149","author":"Trioano","year":"1995","journal-title":"Arch Pediatr Adolesc Med"},{"key":"ref-joc30109-3","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1001\/jama.288.14.1728","article-title":"Prevalence and trends in overweight among US children and adolescents, 1999-2000.","volume":"288","author":"Ogden","year":"2002","journal-title":"JAMA"},{"key":"ref-joc30109-4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/000992289803700208","article-title":"Increased evidence of non-insulin dependent diabetes among Japanese schoolchildren correlates with an increased intake of animal protein and fat.","volume":"37","author":"Kitagawa","year":"1998","journal-title":"Clin Pediatr (Phila)"},{"key":"ref-joc30109-5","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM199211053271904","article-title":"Long-term morbidity and mortality of overweight adolescents: a follow-up of the Harvard Growth Study.","volume":"327","author":"Must","year":"1992","journal-title":"N Engl J Med"},{"key":"ref-joc30109-6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0022-3476(96)80124-7","article-title":"Increased incidence of non-insulin-dependent diabetes mellitus among adolescents.","volume":"128","author":"Pinhas-Hamiel","year":"1996","journal-title":"J Pediatr"},{"key":"ref-joc30109-7","first-page":"11","article-title":"Non-insulin dependent diabetes mellitus in Mexican-American children.","volume":"168","author":"Glaser","year":"1998","journal-title":"West J Med"},{"key":"ref-joc30109-8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/oby.1994.2.issue-1","article-title":"Pharmacotherapy for childhood obesity? maybe for some.","volume":"2","author":"Dietz","year":"1994","journal-title":"Obes Res"},{"key":"ref-joc30109-9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2337\/diacare.21.1.80","article-title":"Early presentation of type 2 diabetes in Mexican-American youth.","volume":"21","author":"Neufeld","year":"1998","journal-title":"Diabetes Care"},{"key":"ref-joc30109-10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2337\/diacare.22.2.345","article-title":"Emerging epidemic of type 2 diabetes in youth.","volume":"22","author":"Rosenbloom","year":"1999","journal-title":"Diabetes Care"},{"key":"ref-joc30109-11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.ijo.0801125","article-title":"Birth weight, climate at birth and the risk of obesity in adult life.","volume":"24","author":"Phillips","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref-joc30109-12","first-page":"235","article-title":"Treatments for childhood and adolescent obesity.","volume":"16","author":"Haddock","year":"1994","journal-title":"Ann Behav Med"},{"key":"ref-joc30109-13","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1038\/sj.ijo.0800860","article-title":"Behavioral treatment of childhood and adolescent obesity.","volume":"23","author":"Robinson","year":"1999","journal-title":"Int J Obes"},{"key":"ref-joc30109-15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/oby.1996.4.issue-3","article-title":"A double-blind randomized placebo-controlled trial of sibutramine.","volume":"4","author":"Bray","year":"1996","journal-title":"Obes Res"},{"key":"ref-joc30109-16","first-page":"S30","article-title":"Sibutramine: a review of clinical efficacy.","volume":"21","author":"Lean","year":"1997","journal-title":"Int J Obes"},{"key":"ref-joc30109-17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/oby.1998.6.issue-1","article-title":"Sibutramine reduces food intake in non-dieting women with obesity.","volume":"6","author":"Rolls","year":"1998","journal-title":"Obes Res"},{"key":"ref-joc30109-18","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/sj.ijo.0801059","article-title":"The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction.","volume":"23","author":"Hansen","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref-joc30109-19","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.2337\/diacare.21.8.1288","article-title":"Role of orlistat in the treatment of obese patients with type 2 diabetes: a 1-year randomized double-blind study.","volume":"21","author":"Hollander","year":"1998","journal-title":"Diabetes Care"},{"key":"ref-joc30109-20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients.","volume":"352","author":"Sjostrom","year":"1998","journal-title":"Lancet"},{"key":"ref-joc30109-21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jama.281.3.235","article-title":"Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.","volume":"281","author":"Davidson","year":"1999","journal-title":"JAMA"},{"key":"ref-joc30109-22","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/ajcn\/69.6.1108","article-title":"Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.","volume":"69","author":"Hill","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"ref-joc30109-24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1542\/peds.85.3.345","article-title":"Obesity in black adolescent girls: a controlled clinical trial by diet, behavior modification, and parental support.","volume":"85","author":"Wadden","year":"1990","journal-title":"Pediatrics"},{"key":"ref-joc30109-28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0022-3999(85)90010-8","article-title":"The Three-Factor Eating Questionnaire to measure dietary restraint, disinhibition and hunger.","volume":"29","author":"Stunkard","year":"1985","journal-title":"J Psychosom Res"},{"key":"ref-joc30109-31","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.2337\/diacare.19.10.1138","article-title":"A prospective analysis of the HOMA model: The Mexico City Diabetes Study.","volume":"19","author":"Haffner","year":"1996","journal-title":"Diabetes Care"},{"key":"ref-joc30109-32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1001\/archinte.161.2.218","article-title":"Benefits of lifestyle modification in the pharmacologic treatment of obesity.","volume":"161","author":"Wadden","year":"2001","journal-title":"Arch Intern Med"},{"key":"ref-joc30109-33","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/oby.2002.77","article-title":"Combining behavioral and pharmacologic treatment for obesity.","volume":"10","author":"Phelan","year":"2002","journal-title":"Obes Res"},{"key":"ref-joc30109-34","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","article-title":"Effect of sibutramine on weight maintenance after weight loss: a randomized trial.","volume":"356","author":"James","year":"2000","journal-title":"Lancet"},{"key":"ref-joc30109-36","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJM199503093321001","article-title":"Changes in energy expenditure resulting from altered body weight.","volume":"332","author":"Leibel","year":"1995","journal-title":"N Engl J Med"},{"key":"ref-joc30109-37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1037\/0278-6133.10.6.378","article-title":"Diminished weight loss and behavioral compliance during repeated diets in obese patients with type II diabetes.","volume":"10","author":"Smith","year":"1991","journal-title":"Health Psychol"},{"key":"ref-joc30109-39","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1542\/peds.105.3.671","article-title":"Type 2 diabetes in children and adolescents.","volume":"105","author":"American Diabetes Association","year":"2000","journal-title":"Pediatrics"},{"key":"ref-joc30109-40","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/oby.1999.7.issue-2","article-title":"Two-year changes in lipids and lipoprotiens associated with the maintenance in a 5% to 10% reduction in initial weight: some findings and some questions.","volume":"7","author":"Wadden","year":"1999","journal-title":"Obes Res"},{"key":"ref-joc30109-41","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/oby.1997.5.issue-3","article-title":"Lifestyle modification in the pharmacologic treatment of obesity: a pilot investigation of a potential primary care approach.","volume":"5","author":"Wadden","year":"1997","journal-title":"Obes Res"},{"key":"ref-joc30109-2","volume-title":"Overweight Among US Children and Adolescents: National Health and Nutrition Examination Survey Data Briefs","author":"Not Available","year":"2002"},{"key":"ref-joc30109-14","first-page":"532","article-title":"Treatment of pediatric obesity.","volume-title":"Handbook of Obesity Treatment","author":"Goldfield","year":"2002"},{"key":"ref-joc30109-23","volume-title":"Meridia (sibutramine hydrochloride) [package insert]","author":"Not Available","year":"2002"},{"key":"ref-joc30109-25","volume-title":"Weight Reduction and Pride (WRAP) Program: Teens' Edition","author":"Wadden","year":"2001"},{"key":"ref-joc30109-26","volume-title":"Weight Reduction and Pride (WRAP) Program: Parents' Edition","author":"Wadden","year":"2001"},{"key":"ref-joc30109-27","first-page":"39","article-title":"Circumferences.","volume-title":"Anthropometric Standardization Manual","author":"Calloway","year":"1988"},{"key":"ref-joc30109-29","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1998"},{"key":"ref-joc30109-30","volume-title":"Epi Info 2002. Database & Statistics Software for Public Health Professionals","author":"Not Available","year":"2002"},{"key":"ref-joc30109-35","first-page":"229","article-title":"The treatment of obesity: an overview.","volume-title":"Handbook of Obesity Treatment","author":"Wadden","year":"2002"},{"key":"ref-joc30109-38","volume-title":"Committee for Proprietary Medicinal Products Opinion Following an Article 31 Referral: Sibutramine","author":"Not Available","year":"2002"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/196346\/joc30109_1805_1812_1708468215.11704.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:30:34Z","timestamp":1708475434000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/196346"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2003,4,9]]},"references-count":41,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2003,4,9]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.289.14.1805","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4,9]]}}}